A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Oxabolone
Fedratinib
The serum concentration of Fedratinib can be increased when it is combined with Erdafitinib.
Oxabolone
Larotrectinib
The serum concentration of Larotrectinib can be increased when it is combined with Erdafitinib.
Oxabolone
Ivosidenib
The serum concentration of Ivosidenib can be increased when it is combined with Erdafitinib.
Oxabolone
Tenofovir
The serum concentration of Tenofovir can be increased when it is combined with Erdafitinib.
Oxabolone
Glecaprevir
The serum concentration of Glecaprevir can be increased when it is combined with Erdafitinib.
Oxabolone
Pibrentasvir
The serum concentration of Pibrentasvir can be increased when it is combined with Erdafitinib.
Oxabolone
Lusutrombopag
The serum concentration of Lusutrombopag can be increased when it is combined with Erdafitinib.
Oxabolone
Grapiprant
The serum concentration of Grapiprant can be increased when it is combined with Erdafitinib.
Oxabolone
Copanlisib
The serum concentration of Copanlisib can be increased when it is combined with Erdafitinib.
Oxabolone
Omadacycline
The serum concentration of Omadacycline can be increased when it is combined with Erdafitinib.
Oxabolone
Rucaparib
The serum concentration of Rucaparib can be increased when it is combined with Erdafitinib.
Oxabolone
Aluminium phosphate
The risk or severity of adverse effects can be increased when Aluminium phosphate is combined with Erdafitinib.
Oxabolone
Calcium silicate
The risk or severity of adverse effects can be increased when Calcium silicate is combined with Erdafitinib.
Oxabolone
Aloglutamol
The risk or severity of adverse effects can be increased when Aloglutamol is combined with Erdafitinib.
Oxabolone
Aluminium glycinate
The risk or severity of adverse effects can be increased when Aluminium glycinate is combined with Erdafitinib.
Oxabolone
Almasilate
The risk or severity of adverse effects can be increased when Almasilate is combined with Erdafitinib.
Oxabolone
Magnesium peroxide
The risk or severity of adverse effects can be increased when Magnesium peroxide is combined with Erdafitinib.
Oxabolone
Hydrotalcite
The risk or severity of adverse effects can be increased when Hydrotalcite is combined with Erdafitinib.
Oxabolone
Aluminium acetoacetate
The risk or severity of adverse effects can be increased when Aluminium acetoacetate is combined with Erdafitinib.
Oxabolone
Magnesium silicate
The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Erdafitinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3